These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 29029887)

  • 1. Long-Term Clinical Safety of High-Dose Proton Radiation Therapy Delivered With Pencil Beam Scanning Technique for Extracranial Chordomas and Chondrosarcomas in Adult Patients: Clinical Evidence of Spinal Cord Tolerance.
    Stieb S; Snider JW; Placidi L; Kliebsch U; Lomax AJ; Schneider RA; Weber DC
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):218-225. PubMed ID: 29029887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
    Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors.
    Gentile MS; Yeap BY; Paganetti H; Goebel CP; Gaudet DE; Gallotto SL; Weyman EA; Morgan ML; MacDonald SM; Giantsoudi D; Adams J; Tarbell NJ; Kooy H; Yock TI
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):719-729. PubMed ID: 29413284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes and Prognostic Factors After Pencil-Beam Scanning Proton Radiation Therapy for Spinal Chordomas: A Large, Single-Institution Cohort.
    Snider JW; Schneider RA; Poelma-Tap D; Stieb S; Murray FR; Placidi L; Albertini F; Lomax A; Bolsi A; Kliebsch U; Malyapa R; Weber DC
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):226-233. PubMed ID: 29619966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report.
    Ares C; Hug EB; Lomax AJ; Bolsi A; Timmermann B; Rutz HP; Schuller JC; Pedroni E; Goitein G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1111-8. PubMed ID: 19386442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton therapy for reirradiation of progressive or recurrent chordoma.
    McDonald MW; Linton OR; Shah MV
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1107-14. PubMed ID: 24267972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Outcomes Study of Proton Therapy for Chordomas and Chondrosarcomas of the Spine.
    Indelicato DJ; Rotondo RL; Begosh-Mayne D; Scarborough MT; Gibbs CP; Morris CG; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):297-303. PubMed ID: 27084648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal cord tolerance to high-dose fractionated 3D conformal proton-photon irradiation as evaluated by equivalent uniform dose and dose volume histogram analysis.
    Marucci L; Niemierko A; Liebsch NJ; Aboubaker F; Liu MC; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):551-5. PubMed ID: 15145175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.
    Pehlivan B; Ares C; Lomax AJ; Stadelmann O; Goitein G; Timmermann B; Schneider RA; Hug EB
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1432-40. PubMed ID: 22349042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas.
    DeLaney TF; Liebsch NJ; Pedlow FX; Adams J; Dean S; Yeap BY; McManus P; Rosenberg AE; Nielsen GP; Harmon DC; Spiro IJ; Raskin KA; Suit HD; Yoon SS; Hornicek FJ
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):732-9. PubMed ID: 19095372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thoracolumbar spinal cord tolerance to high dose conformal proton-photon radiation therapy.
    Chowdhry VK; Liu L; Goldberg S; Adams JA; De Amorim Bernstein K; Liebsch NJ; Niemierko A; Chen YL; DeLaney TF
    Radiother Oncol; 2016 Apr; 119(1):35-9. PubMed ID: 26791929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spot-scanning proton radiation therapy for pediatric chordoma and chondrosarcoma: clinical outcome of 26 patients treated at paul scherrer institute.
    Rombi B; Ares C; Hug EB; Schneider R; Goitein G; Staab A; Albertini F; Bolsi A; Lomax AJ; Timmermann B
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):578-84. PubMed ID: 23582853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small bowel toxicity after high dose spot scanning-based proton beam therapy for paraspinal/retroperitoneal neoplasms.
    Schneider RA; Vitolo V; Albertini F; Koch T; Ares C; Lomax A; Goitein G; Hug EB
    Strahlenther Onkol; 2013 Dec; 189(12):1020-5. PubMed ID: 24052010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer.
    Cuaron JJ; Chon B; Tsai H; Goenka A; DeBlois D; Ho A; Powell S; Hug E; Cahlon O
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):284-91. PubMed ID: 25754632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective clinical trial of proton therapy for chordoma and chondrosarcoma: Feasibility assessment.
    Baumann BC; Lustig RA; Mazzoni S; Grady SM; O'Malley BW; Lee JYK; Newman JG; Schuster JM; Both S; Lin A; Dorsey JF; Alonso-Basanta M
    J Surg Oncol; 2019 Aug; 120(2):200-205. PubMed ID: 31111502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated stereotactic radiation therapy for skull base and upper cervical chordoma and chondrosarcoma: preliminary results.
    Gwak HS; Yoo HJ; Youn SM; Chang U; Lee DH; Yoo SY; Rhee CH
    Stereotact Funct Neurosurg; 2005; 83(5-6):233-43. PubMed ID: 16601376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reirradiation human spinal cord tolerance for stereotactic body radiotherapy.
    Sahgal A; Ma L; Weinberg V; Gibbs IC; Chao S; Chang UK; Werner-Wasik M; Angelov L; Chang EL; Sohn MJ; Soltys SG; Létourneau D; Ryu S; Gerszten PC; Fowler J; Wong CS; Larson DA
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):107-16. PubMed ID: 20951503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
    Gillmann C; Jäkel O; Schlampp I; Karger CP
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity.
    Gordon K; Gulidov I; Koryakin S; Smyk D; Makeenkova T; Gogolin D; Lepilina O; Golovanova O; Semenov A; Dujenko S; Medvedeva K; Mardynsky Y
    Radiat Oncol; 2021 Dec; 16(1):238. PubMed ID: 34930352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative proton therapy for chordomas and chondrosarcomas of the spine: adjuvant versus salvage radiation therapy.
    Holliday EB; Mitra HS; Somerson JS; Rhines LD; Mahajan A; Brown PD; Grosshans DR
    Spine (Phila Pa 1976); 2015 Apr; 40(8):544-9. PubMed ID: 25627289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.